Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know

Analysts' mean price target for Janux Therapeutics (JANX) implies 155.8% upside, indicating a notably bullish sell-side view. The article also notes strong agreement among analysts in raising earnings estimates, which supports a more constructive outlook for the stock. This is positive for sentiment, but it is still largely analyst commentary rather than a company-specific catalyst.

Analysis

Analysts' mean price target for Janux Therapeutics (JANX) implies 155.8% upside, indicating a notably bullish sell-side view. The article also notes strong agreement among analysts in raising earnings estimates, which supports a more constructive outlook for the stock. This is positive for sentiment, but it is still largely analyst commentary rather than a company-specific catalyst.